Status: current, Defined. Date: 31-Aug 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2529831000168110 | Ibrance (palbociclib 125 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2529841000168118 | Ibrance 125 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ibrance 125 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Ibrance 125 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ibrance 125 mg capsule | Is a | Ibrance | true | Inferred relationship | Some | ||
| Ibrance 125 mg capsule | Is a | palbociclib 125 mg capsule | true | Inferred relationship | Some | ||
| Ibrance 125 mg capsule | has manufactured dose form | hard capsule | false | Inferred relationship | Some | ||
| Ibrance 125 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 1664013179 | |
| Ibrance 125 mg capsule | has intended active ingredient | palbociclib | true | Inferred relationship | Some | 1664013178 | |
| Ibrance 125 mg capsule | has Australian BoSS | palbociclib | true | Inferred relationship | Some | 1664013178 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ibrance 125 mg capsule, 21, blister pack | has TPUU | True | Ibrance 125 mg capsule | Inferred relationship | Some | 1 |
| Ibrance 125 mg capsule, 21 | has TPUU | True | Ibrance 125 mg capsule | Inferred relationship | Some | 1 |
| Ibrance 125 mg capsule, 21, bottle | has TPUU | True | Ibrance 125 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR